Basic Info

Common Name1,1-Dichloropropene(F04435)
2D Structure
Description

1,1-Dichloropropene is a industrial solvent; no information on specific uses is available in standard government and industry sources (L893).

FRCD IDF04435
CAS Number563-58-6
PubChem CID11245
FormulaC3H4Cl2
IUPAC Name

1,1-dichloroprop-1-ene

InChI Key

ZAIDIVBQUMFXEC-UHFFFAOYSA-N

InChI

InChI=1S/C3H4Cl2/c1-2-3(4)5/h2H,1H3

Canonical SMILES

CC=C(Cl)Cl

Isomeric SMILES

CC=C(Cl)Cl

Synonyms
        
            1,1-Dichloropropylene
        
            1,1-DICHLOROPROPENE
        
            563-58-6
        
            1,1-Dichloro-1-propene
        
            1-Propene, 1,1-dichloro-
        
            Propene, 1,1-dichloro-
        
            1,1-dichloroprop-1-ene
        
            CCRIS 9037
        
            UNII-5C5688865R
        
            NSC 6201
        
Classifies
                

                  
                    Pesticide
                  

                
        
Update DateNov 13, 2018 17:07

Chemical Taxonomy

KingdomOrganic compounds
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds
SubclassKetene acetals
Intermediate Tree NodesNot available
Direct ParentKetene acetals
Alternative Parents
Molecular FrameworkAliphatic acyclic compounds
SubstituentsKetene acetal or derivatives - Chloroalkene - Haloalkene - Vinyl halide - Vinyl chloride - Hydrocarbon derivative - Organochloride - Organohalogen compound - Aliphatic acyclic compound
DescriptionThis compound belongs to the class of organic compounds known as ketene acetals. These are organic compounds comprising the ketene acetal functional group, with the general structure XC(Y)=C(R3)R4 (R1,R2=H, alkyl, aryl; X,Y=any hetero atom).

Properties

Property NameProperty Value
Molecular Weight110.965
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count0
Rotatable Bond Count0
Complexity42.9
Monoisotopic Mass109.969
Exact Mass109.969
XLogP2.6
Formal Charge0
Heavy Atom Count5
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

ADMET

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9682
Human Intestinal AbsorptionHIA+1.0000
Caco-2 PermeabilityCaco2+0.6640
P-glycoprotein SubstrateNon-substrate0.8390
P-glycoprotein InhibitorNon-inhibitor0.9521
Non-inhibitor0.9826
Renal Organic Cation TransporterNon-inhibitor0.9103
Distribution
Subcellular localizationLysosome0.5072
Metabolism
CYP450 2C9 SubstrateNon-substrate0.7718
CYP450 2D6 SubstrateNon-substrate0.9115
CYP450 3A4 SubstrateNon-substrate0.6674
CYP450 1A2 InhibitorNon-inhibitor0.6708
CYP450 2C9 InhibitorNon-inhibitor0.8217
CYP450 2D6 InhibitorNon-inhibitor0.9292
CYP450 2C19 InhibitorNon-inhibitor0.7425
CYP450 3A4 InhibitorNon-inhibitor0.8825
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.7521
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.9353
Non-inhibitor0.9508
AMES ToxicityNon AMES toxic0.6308
CarcinogensCarcinogens 0.7685
Fish ToxicityHigh FHMT0.8220
Tetrahymena Pyriformis ToxicityHigh TPT0.9261
Honey Bee ToxicityHigh HBT0.8820
BiodegradationNot ready biodegradable0.8759
Acute Oral ToxicityIII0.8610
Carcinogenicity (Three-class)Non-required0.5474

Model Value Unit
Absorption
Aqueous solubility-2.4089LogS
Caco-2 Permeability1.5000LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.2197LD50, mol/kg
Fish Toxicity1.5577pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.4161pIGC50, ug/L

Targets

General Function:
Zinc ion binding
Specific Function:
Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
Gene Name:
ESR1
Uniprot ID:
P03372
Molecular Weight:
66215.45 Da
Mechanism of Action:
Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor.
References
  1. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stuffler RG, Tedesco M, Maccarrone M: N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int. 2006 Apr;69(8):1450-4. [16531984 ]
General Function:
Zinc ion binding
Specific Function:
Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner (PubMed:20074560). Isoform beta-cx lacks ligand binding ability and has no or only very low ere binding activity resulting in the loss of ligand-dependent transactivation ability. DNA-binding by ESR1 and ESR2 is rapidly lost at 37 degrees Celsius in the absence of ligand while in the presence of 17 beta-estradiol and 4-hydroxy-tamoxifen loss in DNA-binding at elevated temperature is more gradual.
Gene Name:
ESR2
Uniprot ID:
Q92731
Molecular Weight:
59215.765 Da
Mechanism of Action:
Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor.
References
  1. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stuffler RG, Tedesco M, Maccarrone M: N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int. 2006 Apr;69(8):1450-4. [16531984 ]
General Function:
Temperature-gated cation channel activity
Specific Function:
Receptor-activated non-selective cation channel involved in detection of pain and possibly also in cold perception and inner ear function (PubMed:25389312, PubMed:25855297). Has a central role in the pain response to endogenous inflammatory mediators and to a diverse array of volatile irritants, such as mustard oil, cinnamaldehyde, garlic and acrolein, an irritant from tears gas and vehicule exhaust fumes (PubMed:25389312, PubMed:20547126). Is also activated by menthol (in vitro)(PubMed:25389312). Acts also as a ionotropic cannabinoid receptor by being activated by delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana (PubMed:25389312). May be a component for the mechanosensitive transduction channel of hair cells in inner ear, thereby participating in the perception of sounds. Probably operated by a phosphatidylinositol second messenger system (By similarity).
Gene Name:
TRPA1
Uniprot ID:
O75762
Molecular Weight:
127499.88 Da
References
  1. Nilius B, Prenen J, Owsianik G: Irritating channels: the case of TRPA1. J Physiol. 2011 Apr 1;589(Pt 7):1543-9. doi: 10.1113/jphysiol.2010.200717. Epub 2010 Nov 15. [21078588 ]